Portfolio company
Alithea Genomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces high-throughput RNA sequencing kits and services for pharmaceutical researchers performing drug discovery, biomarker identification and toxicology screening.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Arpeggio Biosciences
The company provides a transcriptomics platform to map drug effects on gene expression for pharmaceutical and biotechnology partners developing novel therapeutics.
Arima Genomics
This company develops 3D genomic sequencing kits and clinical diagnostic tests for researchers and pharmaceutical companies to identify cancer-driving genetic alterations.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
ORIG3N
This biotechnology company develops direct-to-consumer genetic testing kits and maintains a biorepository of stem cells to support medical researchers and pharmaceutical firms in drug discovery.
